New studies reveal a strong link between depression and mood disorders in mid to late life and the risk of developing ...

BioArctic AB (publ) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be ...

How did we get here, to the point where so many of us are isolated, and still can’t reach out? Check out new research, and ...

Aging Together, Mom2Mom, Free Clinic, Carver Food Enterprise, Culpeper Food Closet, Girls on the Run all beneficiaries of Culpeper Wellness Foundation funding.